Association between E-cadherin (CDH1) polymorphisms and papillary thyroid carcinoma risk in Han Chinese population

Endocrine

Volumn 41, Issue 3, 2012, Pages 526-531

  Wang, Ying Xue ^a   Zhao, Lei ^b   Wang, Xiu Yun ^a   Liu, Chang Mei ^a   Yu, Su Guo ^a  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Allele; E cadherin; Papillary thyroid carcinoma; Polymorphism

Indexed keywords

UVOMORULIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CANCER STAGING; CDH1 GENE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA; TUMOR VOLUME;

EID: 84862686158     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9582-y     Document Type: Article

References (35)

1. Y.E. Nikiforov, Is ionizing radiation responsible for the increasing incidence of thyroid cancer? Cancer 116(7), 1626-1628 (2010). doi:10.1002/cncr.24889
2. L. Hegedus, Clinical practice. The thyroid nodule. N. Engl. J. Med. 351(17), 1764-1771 (2004). doi:10.1056/NEJMcp031436 (Pubitemid 39383211)
3. R. Paschke, K.W. Schmid, R. Gartner, K. Mann, H. Dralle, C. Reiners, Epidemiology, pathophysiology, guideline-adjusted diagnostics, and treatment of thyroid nodules. Med. Klin. (Munich) 105(2), 80-87 (2010). doi:10.1007/s00063- 010-1011-9
4. D.S. Dean, H. Gharib, Epidemiology of thyroid nodules. Best Pract. Res. Clin. Endocrinol. Metab. 22(6), 901-911 (2008). doi: 10.1016/j.beem.2008.09.019
5. C. Martinez-Rico, F. Pincet, J.P. Thiery, S. Dufour, Integrins stimulate E-cadherin-mediated intercellular adhesion by regulating Src-kinase activation and actomyosin contractility. J. Cell Sci. 123(Pt 5), 712-722 (2010). doi:10.1242/jcs.047878
6. J. Kucharczak, S. Charrasse, F. Comunale, J. Zappulla, B. Robert, I. Teulon-Navarro, A. Pelegrin, C. Gauthier-Rouviere, R-Cadherin expression inhibits myogenesis and induces myoblast transformation via Rac1 GTPase. Cancer Res. 68(16), 6559-6568 (2008). doi:10.1158/0008-5472.CAN-08-0196
7. S.C. Suzuki, M. Takeichi, Cadherins in neuronal morphogenesis and function. Dev. Growth Differ. 1(50 Suppl), S119-S130 (2008). doi:10.1111/j.1440-169X.2008.01002.x (Pubitemid 351725072)
8. H.C. Chen, R.Y. Chu, P.N. Hsu, P.I. Hsu, J.Y. Lu, K.H. Lai, H.H. Tseng, N.H. Chou, M.S. Huang, C.J. Tseng, M. Hsiao, Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas. Cancer Lett. 201(1), 97-106 (2003) (Pubitemid 37298002)
9. U. Cavallaro, G. Christofori, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer 4(2), 118-132 (2004) (Pubitemid 38198740)
10. K.S. Nadella, G.N. Jones, A. Trimboli, C.A. Stratakis, G. Leone, L.S. Kirschner, Targeted deletion of Prkar1a reveals a role for protein kinase A in mesenchymal-to-epithelial transition. Cancer Res. 68(8), 2671-2677 (2008). doi:10.1158/0008-5472.CAN-07-6002 (Pubitemid 351556264)
11. A. Mitselou, E. Ioachim, D. Peschos, K. Charalabopoulos, M. Michael, N.J. Agnantis, T. Vougiouklakis, E-cadherin adhesion molecule and syndecan-1 expression in various thyroid pathologies. Exp Oncol 29(1), 54-60 (2007) (Pubitemid 46713481)
12. E. Brecelj, S. Frkovic Grazio, M. Auersperg, M. Bracko, Prognostic value of E-cadherin expression in thyroid follicular carcinoma. Eur. J. Surg. Oncol. 31(5), 544-548 (2005). doi:10.1016/j.ejso.2005.02.003 (Pubitemid 40724097)
13. A.S. Rocha, P. Soares, E. Fonseca, J. Cameselle-Teijeiro, M.C. Oliveira, M. Sobrinho-Simoes, E-cadherin loss rather than betacatenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology 42(6), 580-587 (2003) (Pubitemid 36688152)
14. G. Serini, L. Trusolino, E. Saggiorato, O. Cremona, M. De Rossi, A. Angeli, F. Orlandi, P.C. Marchisio, Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J. Natl. Cancer Inst. 88(7), 442-449 (1996) (Pubitemid 26097060)
15. P. Soares, G. Berx, F. van Roy, M. Sobrinho-Simoes, E-cadherin gene alterations are rare events in thyroid tumors. Int. J. Cancer 70(1), 32-38 (1997). doi:10.1002/(SICI)1097-0215(19970106) 70:1\32:AID-IJC5[3.0.CO;2-7 (Pubitemid 27059702)
16. A.S. Rocha, P. Soares, R. Seruca, V. Maximo, X. Matias-Guiu, J. Cameselle-Teijeiro, M. Sobrinho-Simoes, Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J. Pathol. 194(3), 358-366 (2001). doi:10.1002/path.905 (Pubitemid 32624563)
17. A. Nakamura, T. Shimazaki, K. Kaneko, M. Shibata, T. Matsumura, M. Nagai, R. Makino, K. Mitamura, Characterization of DNA polymorphisms in the E-cadherin gene (CDH1) promoter region. Mutat. Res. 502(1-2), 19-24 (2002) (Pubitemid 34454994)
18. Y. Shin, I.J. Kim, H.C. Kang, J.H. Park, H.R. Park, H.W. Park, M.A. Park, J.S. Lee, K.A. Yoon, J.L. Ku, J.G. Park, The E-cadherin -347G[GA promoter polymorphism and its effect on transcriptional regulation. Carcinogenesis 25(6), 895-899 (2004). doi:10.1093/carcin/bgh073 (Pubitemid 38886075)
19. L.C. Li, R.M. Chui, M. Sasaki, K. Nakajima, G. Perinchery, H.C. Au, D. Nojima, P. Carroll, R. Dahiya, A single nucleotide polymorphism in the E-cadherin gene promoter alters transcriptional activities. Cancer Res. 60(4), 873-876 (2000) (Pubitemid 30129518)
20. H. Yamada, K. Shinmura, S. Ikeda, H. Tao, T. Otani, T. Hanaoka, T. Tsuneyoshi, S. Tsugane, H. Sugimura, Association between CDH1 haplotypes and gastric cancer risk in a Japanese population. Scand. J. Gastroenterol. 42(12), 1479-1485 (2007). doi: 10.1080/00365520701478436 (Pubitemid 350125545)
21. L. Gao, A. Nieters, H. Brenner, Meta-analysis: tumour invasionrelated genetic polymorphisms and gastric cancer susceptibility. Aliment. Pharmacol. Ther. 28(5), 565-573 (2008). doi:10.1111/j.1365-2036.2008.03760.x
22. S.B. Edge, American Joint Committee on Cancer: AJCC Cancer Staging Manual, 7th edn. (Springer, New York, 2010)
23. F. van Roy, G. Berx, The cell-cell adhesion molecule E-cadherin. Cell. Mol. Life Sci. 65(23), 3756-3788 (2008). doi:10.1007/s00018-008-8281-1
24. S. Baranwal, S.K. Alahari, Molecular mechanisms controlling E-cadherin expression in breast cancer. Biochem. Biophys. Res. Commun. 384(1), 6-11 (2009). doi:10.1016/j.bbrc.2009.04.051
25. A. Jeanes, C.J. Gottardi, A.S. Yap, Cadherins and cancer: how does cadherin dysfunction promote tumor progression? Oncogene 27(55), 6920-6929 (2008). doi:10.1038/onc.2008.343
26. H.J. Martens, V. Geenen, Focal adhesion kinases: interest in immunoendocrinology, developmental biology, and cancer. Endocrine 13(3), 233-242 (2000). doi:10.1385/ENDO:13:3:233 (Pubitemid 32108049)
27. F. Cattaneo, T. Venesio, S. Molatore, A. Russo, R. Fiocca, M. Frattini, A.I. Scovassi, L. Ottini, L. Bertario, G.N. Ranzani, Functional analysis and case-control study of -160C/A polymorphism in the E-cadherin gene promoter: association with cancer risk. Anticancer Res. 26(6B), 4627-4632 (2006) (Pubitemid 46031541)
28. X.F. Zhang, Y.M. Wang, H. Ge, Y.Y. Cao, Z.F. Chen, D.G. Wen, W. Guo, N. Wang, Y. Li, J.H. Zhang, Association of CDH1 single nucleotide polymorphisms with susceptibility to esophageal squamous cell carcinomas and gastric cardia carcinomas. Dis Esophagus 21(1), 21-29 (2008). doi:10.1111/j.1442-2050.2007. 00724.x
29. M.S. Al-Moundhri, M. Al-Khanbashi, M. Al-Kindi, M. Al- Nabhani, I.A. Burney, A. Al-Farsi, B. Al-Bahrani, Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk. World J. Gastroenterol. 16(27), 3432-3436 (2010)
30. B. Zhang, K. Pan, Z. Liu, J. Zhou, L. Gu, J. Ji, J. Ma, W.C. You, D. Deng, Genetic polymorphisms of the E-cadherin promoter and risk of sporadic gastric carcinoma in Chinese populations. Cancer Epidemiol. Biomarkers Prev. 17(9), 2402-2408 (2008). doi: 10.1158/1055-9965.EPI-08-0315
31. J.G. Kim, Y.S. Chae, S.K. Sohn, Y.Y. Cho, J.H. Moon, J.Y. Park, S.W. Jeon, I.T. Lee, G.S. Choi, S.H. Jun, Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin. Cancer Res. 14(1), 62-66 (2008). doi:10.1158/1078-0432.CCR-07-1537 (Pubitemid 351377979)
32. H. Tsukino, Y. Kuroda, H. Nakao, H. Imai, H. Inatomi, K. Kohshi, Y. Osada, T. Katoh, E-cadherin gene polymorphism and risk of urothelial cancer. Cancer Lett. 195(1), 53-58 (2003) (Pubitemid 36588978)
33. M.S. Wu, S.P. Huang, Y.T. Chang, M.T. Lin, C.T. Shun, M.C. Chang, H.P. Wang, C.J. Chen, J.T. Lin, Association of the -160 C-> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk. Cancer 94(5), 1443-1448 (2002). doi: 10.1002/cncr.10371 (Pubitemid 34212638)
34. J.C. Yu, H.M. Hsu, S.T. Chen, G.C. Hsu, C.S. Huang, M.F. Hou, Y.P. Fu, T.C. Cheng, P.E. Wu, C.Y. Shen, Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility. J. Biomed. Sci. 13(3), 419-432 (2006). doi: 10.1007/s11373-006-9069-7
35. H. Lei, S. Sjoberg-Margolin, S. Salahshor, B. Werelius, E. Jandakova, K. Hemminki, A. Lindblom, I. Vorechovsky, CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk. Int. J. Cancer 98(2), 199-204 (2002). doi:10.1002/ijc.10176 (Pubitemid 34150802)